According to Intent Market Research, the Digital Health Market is expected to grow from USD 181.0 billion in 2023-e at a CAGR of 6.4% to touch USD 279.4 billion by 2030. The digital health market is dominated by key players such as Abbott, Beckman Coulter, Boston Scientific, Medtronic, J&J MedTech, Philips Healthcare, GE Healthcare, Siemens Healthineers, Teladoc, Samsung Healthcare, and McKesson.

According to Intent Market Research, the Ventilators Market is expected to grow from USD 4.8 billion in 2023-e at a CAGR of 7.5% to touch USD 7.9 billion by 2030. The ventilators market is competitive, the prominent players in the global market include ABM Respiratory Care, Airon, Baxter International, Bio-Medical Electronics, Drägerwerk, GE Healthcare, Getinge AB, Hamilton Medical, ICU Medical, Philips, Medtronic, Metran, Shenzhen Mindray, and Vyaire Medical.

According to Intent Market Research, the Robotic Dentistry Market is expected to grow from USD 410 million in 2023-e at a CAGR of 18.3% to touch USD 1,329.5 million by 2030. The robotic dentistry market is competitive, the prominent players in the global market include 3Shape, Align Technology, Beijing Baihui Weikang Technology, Dentsply Sirona, Envista Holdings, Intutuive Surgical, Image Navigation, Neocis, Planmeca, and Zimmer Biomet.

According to Intent Market Research, the RNA Analysis Market is expected to grow from USD 5.5 billion in 2023-e at a CAGR of 10.8% to touch USD 10.3 billion by 2030. The RNA analysis market is competitive, the prominent players in the global market include Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others.

According to Intent Market Research, the Precision Medicine Market is expected to grow from USD 30.7 billion in 2023-e at a CAGR of 11.4% to touch USD 59.3 billion by 2030. The precision medicine market is competitive, the prominent players in the global market include AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Catalent, Eli Lilly, Gilead Sciences, Johnson & Johnson, Lonza, Merck, Novartis, Parexel, Pfizer, Roche, Sanofi, Takeda Pharmaceutical, amongst others.

The Plasma Fractionation Market is expected to grow from USD 31.7 billion in 2023-e to USD 50.1 billion by 2030, at a CAGR of 7.8%.

The microfluidics market is expected to grow from USD 23.1 billion in 2023-e to USD 51.0 billion by 2030, at a CAGR of 14.0% during the forecast period. The microfluidics market is a competitive market, the prominent players in the global market include Agilent Technologies, Beckton Dickinson and Company, Biomérieux, Bio-Rad, Danaher Corporation, Fluidigm Corporation, Hologic, Illumina, PerkinElmer, Roche, Thermo Fisher Scientific.

According to Intent Market Research, the Continuous Renal Replacement Therapy (CRRT) Market is expected to grow from USD 1.5 billion in 2023-e at a CAGR of 7.8% to touch USD 2.0 billion by 2030. The CRRT market is competitive, the prominent players in the global market include Asahi Kasei Medical, B. Braun, Baxter International, Cytosorbents, Fresenius Medical Care, Infomed SA, Medtronic, Nikkiso, NIPRO, Toray Medical.

According to Intent Market Research, the clinical decision support systems market is expected to grow from USD 1.9 billion in 2023-e at a CAGR of 8.1% to touch USD 3.1 billion by 2030. The clinical decision support systems market is competitive, the prominent players in the global market include 3M Health Information Systems, Allscripts, Cerner Corporation, Change Healthcare, Elsevier BV, Epic Systems, GE Healthcare, IBM Watson Health, McKesson Corporation, Meditech, NextGen Healthcare, Oracle, Philips Healthcare, Siemens Healthineers, and Wolters Kluwer Health.

According to Intent Market Research, the Cardiac Marker Testing Market is expected to grow from USD 4.8 billion in 2023-e at a CAGR of 10.3% to touch USD 9.7 billion by 2030. The cardiac marker testing is a competitive market, the prominent players in the global market include Abbott, BD, bioMérieux, Bio-Rad, Danaher, DiaSorin, LSI Medience, PerkinElmer, Quidel, Roche, Siemens, Thermo Fisher Scientific, and Tosoh.

According to Intent Market Research, the Biofabrication Market is expected to grow from USD 21.0 billion in 2023-e at a CAGR of 7.3% to touch USD 34.8 billion by 2030. Prominent players include Allevi, Cellink Global, Cyfuse Biomedical, Danaher, Envisiontec, Eppendorf, Inventia Life Science, Merck, Organovo Holdings, Poietis, Regemat 3D, Sartorius Stedim Biotech, Thermo Fisher Scientific, Vivax Bio and 3D Bioprinting Solutions.

According to Intent Market Research, the AI in Drug Discovery Market is expected to grow from USD 850 million in 2023-e at a CAGR of 40.5% to touch USD 4,500 million by 2030. The AI in drug discovery market is a competitive market, the prominent players in the global market include BenevolentAI, BioXcel Therapeutics, Deep Genomics, Exscientia, Google, Insilico Medicine, IQVIA, Labcorp, Microsoft, NVIDIA, and Recursion.

According to Intent Market Research, the Medical Device Validation and Verification Market is expected to grow from USD 10.8 billion in 2023-e at a CAGR of 4.7% to touch USD 14.8 billion by 2030. The medical device validation and verification is a competitive market, the prominent players in the global market include BSI Group, Bureau Veritas, Charles River, DekraTesting and Certification, Element Materials Technology. Eurofins Scientific, Intertek Group, Pace Analytical Services, Quest Global, SGS, Sterling Medical Devices, TUV Rheinland, WuXi AppTe.

The laboratory proficiency testing market is expected to grow from USD 1.3 billion in 2023-e to USD 2.1 billion by 2030, at a CAGR of 6.8% during the forecast period. The laboratory proficiency testing is a competitive market, the prominent players in the global market include American Proficiency Institute, AOAC International, Bio-Rad, BIPEA, College of American Pathologists, Fapas, INSTAND, LGC, Merck, NSI Lab Solutions, QACS, Randox, Trilogy, Waters, and Weqas.

The Image-guided Radiation Therapy (IGRT) market is expected to grow from USD 1.7 billion in 2023-e to USD 2.4 billion by 2030, at a CAGR of 5.3% during the forecast period. The IGRT is a competitive market, the prominent players in the global market include Accuray, Canon, C-Rad, Elekta, GE Healthcare, GenesisCare, Mevion, Philips, RefleXion, Siemens, Sun Nuclear, ViewRay, and Vision RT.

The clinical trial supplies market is expected to grow from USD 4.3 billion in 2023-e to USD 8.7 billion by 2030, at a CAGR of 10.2% during the forecast period. The clinical trial supplies market is a competitive market, the prominent players in the global market include Almac Group, Biocair, Catalent, Eurofins Scientific, Nuvisan, Lonza Group, PCI Pharma Services, Piramal Pharma Solutions, PRA Health Sciences, Sharp Services, and Thermo Fisher Scientific.

The breast biopsy devices market is expected to grow from USD 1.8 billion in 2023-e to USD 3.4 billion by 2030, at a CAGR of 9.7% during the forecast period. The breast biopsy devices market is a competitive market, the prominent players in the global market include Argon Medical Devices, Becton Dickinson and Company, Cook Medical, Devicor Medical Products, F. Hoffmann-La Roche, GE Healthcare, Hologic, Leica Biosystems, Medax Srl, Planmed, Scion Medical Technologies, and Siemens Healthier.

The biomarkers market is expected to grow from USD 79.3 billion in 2023-e to USD 187.4 billion by 2030, at a CAGR of 14.7% during the forecast period. The biomarkers market is dominated by key players such as Amgen, Biogen, Biognosys, Bio-rad, Chordia Therapeutics, Epigenomics, Evotec, Koneksa, Myriad Genetics, Quanterix, Sengenics, Siemens, Thermo Fisher Scientific, and Veravas.

The acquisition of smaller players and product innovations by major players are driving the AI in cell and gene therapy market. The AI in cell and gene therapy market is a competitive market, the prominent players in the global market include Dyno Therapeutics, Exelixis, Form Bio, Généthon, DeepMind (Google), IBM, Insilico, Microsoft, Nosis Bio, Oxford BioMedica, SK Pharmteco, Thales